NCT00239460 - Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD | Biotech Hunter

Enrollment

196

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

March 31, 2004

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium

Trial Locations (12)

Attn: William C. Bailey, M.D., Birmingham

Boehringer Ingelheim Investigational Site, Phoenix

Olive View UCLA Medical Center, Sylmar

Rocky Mountain Center for Clinical Research, Wheat Ridge

Respiratory Diseases (111A), Bay Pines

Boehringer Ingelheim Investigational Site, Pembroke Pines

Boehringer Ingelheim Investigational Site, Coeur d'Alene

LSU Health Sciences Center, Shreveport

Pulmonary and Critical Care Services, PC, Albany

The Oregon Clinic, Portland

Boehringer Ingelheim Investigational Site, Charleston

Boehringer Ingelheim Investigational Site, Houston